Gwenn Hansen Email

CSO . Nurix

San Francisco, CA

Location

g******@nurixtx.com

Primary Email

Current Roles

Employees:
296
Revenue:
$42.6M
About
Nurix, Inc. is a leader in discovering and developing therapies that modulate the ubiquitin proteasome system (UPS). The UPS is a regulatory pathway that directs protein degradation, a function vital to the healthy life of a cell, and presents therapeutic opportunities in multiple disease areas, including oncology. Nurix’s state-of–the-art product engine leverages a deep mechanistic understanding of the UPS to deliver effective small molecule drug candidates with the potential to make a dramatic difference for patients. Nurix was founded by internationally recognized experts in the ubiquitin proteasome field and is funded by leading life science investors, Third Rock Ventures and The Column Group. The company is headquartered in San Francisco, California.
Nurix Address
1700 Owens Street
San Francisco, CA
United States

Past Companies

Nurix TherapeuticsCSO
Nurix TherapeuticsSenior Vice President, Research
Nurix TherapeuticsVice President, Drug Discovery

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.